VASCONCELLES MICHAEL
SEC insider (Form 3/4/5 filer). CIK 0001734755. Director at Kura Oncology, Inc. (KURA) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in SAN DIEGO, CA.
Companies VASCONCELLES MICHAEL has filed insider reports for
- Kura Oncology, Inc. (KURA): Director
- Day One Biopharmaceuticals, Inc. (DAWN): Officer, Head of Research and Dev.
VASCONCELLES MICHAEL
CIK: 0001734755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 4, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
35K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirect4.4K shares- - Feb 17, 2026DAWN
Day One Biopharmaceuticals, Inc.
SaleDirect2.7K shares at avg. $11.60$32K - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect7.1K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectRestricted Stock Units
114K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectStock Option (right to buy Common Stock)
171K shares- - Jun 16, 2025DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectStock Option (right to buy Common Stock)
346K shares- - Jun 16, 2025DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectRestricted Stock Unit (RSU)
226K shares- - Jun 5, 2025KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
28.5K shares- - Sep 13, 2024KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
17.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award Option to purchase common stock | 35,000 | - | - | Direct |
| Apr 23, 2026 |  DAWN Day One Biopharmaceuticals, Inc. | Disposition | 4,397 | - | $0 | Direct |
| Feb 17, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Sale | 2,728 | $11.60 | $31,647 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 7,125 | - | $0 | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award Restricted Stock Units | 114,000 | - | - | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award Stock Option (right to buy Common Stock) | 171,000 | - | - | Direct |
| Jun 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Award Stock Option (right to buy Common Stock) | 346,000 | - | - | Direct |
| Jun 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Award Restricted Stock Unit (RSU) | 226,000 | - | - | Direct |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | Award Option to purchase common stock | 28,500 | - | - | Direct |
| Sep 13, 2024 | KURA Kura Oncology, Inc. | Award Option to purchase common stock | 17,333 | - | - | Direct |
1-10 of 11 transactions